glp 1 safety long term Addressing patient concerns about the 'newness' and long-term of GLP- receptor agonists: A clinician's guide to counseling glp-1 long term safety Researchers

Cardiovascular Disease and Risk Management: standards of Medical Care in Diabetes-2018

As a functional medicine physician who has helped thousands of patients optimize their metabolic health, I've seen firsthand how the right combination of nutrition, lifestyle modifications, and strategic supplementation can help maintain weight loss and even enhance your body's natural GLP-1 production

Even with a shorter half-life than semaglutide, clinical trials and FDA approvals still mandate a seven-day dosing interval to ensure patient safety and predictable outcomes

I.Evrard-TodeschiN.InnamoratoN

10.1016/S2213-2600(13)70286-8 Lancet Respir Med